Newsroom
Category
November 5, 2021
A large, multi-site study funded by the National Institutes of Health aims to test the effectiveness of three existing drugs, including controversial ivermectin, to treat the symptoms of COVID-19. Known as ACTIV-6, the study is now underway at UT Health San Antonio.
November 4, 2021
This quick and helpful Q&A video speaks to vaccine symptoms, the importance of booster shots and other timely topics.
November 1, 2021
On Oct. 26, the Food and Drug Administration approved COVID-19 vaccinations for children ages 5 to 11. The decision will now go before the CDC Advisory Committee on Immunization Practices’ (ACIP) for a final recommendation Nov. 2-3.
October 29, 2021
Researchers at The University of Texas Health Science Center at San Antonio, who see patients at University Health, are recruiting 900 adult COVID-19 survivors for a federally funded study that seeks to understand why some people have prolonged symptoms or develop new or returning symptoms after the acute phase of SARS-CoV-2 infection. The partnership also includes the Laredo Health Department as a clinical partner in this major effort.
October 26, 2021
Lindsay Fry is a breast cancer survivor who was first diagnosed in 2019. Her treatment regimen of surgery, radiation and chemotherapy began in fall 2019. Shortly after completing her treatment, Fry became the first participant in a new clinical trial at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) that aims to help breast cancer survivors regain their energy and remain cancer free.
October 25, 2021
UT Health San Antonio medical and scientific experts are preparing a public education campaign about the importance of getting COVID-19 vaccinations now to prevent the possibility of a winter surge. The organization also is preparing to provide COVID-19 vaccinations for children ages 5-11 when the vaccine receives emergency use authorization, which is expected in early November.
